Apolipoprotein E phenotypes in demented and cognitively impaired patients with and without cerebrovascular disease
- 1 July 1999
- journal article
- clinical trial
- Published by Wiley in European Journal of Neurology
- Vol. 6 (4) , 415-421
Abstract
Controversy exists regarding the apolipoprotein E (ApoE) ɛ4 allele association with vascular dementia (VaD), ranging from increased ɛ4 frequency, similar to that found for Alzheimer's disease (AD), to no association between the ɛ4 allele and VaD. To clarify further the relationship between ApoE alleles polymorphism and cerebrovascular disease (CVD) in demented and cognitively impaired patients, we examined the ApoE phenotypes in a sample of 280 patients: 155 with AD, 21 with VaD, 32 with mixed dementia (MD), 45 with mild cognitive impairment (MCI) but without CVD, and 27 in which vascular disease was the most probable cause of cognitive decline [vascular mild cognitive impairment (VMCI)]. Our results show that the frequency of the ApoE ɛ4 allele in patients over 70 years old with clinically diagnosed VaD and VMCI does not differ significantly from that of controls. In contrast, ApoE ɛ4 allele‐bearing individuals had greater risk of having late‐onset AD (OR=8.8; 95% Cl 3.7–21.0), or non‐vascular cognitive impairment (OR=7.0; 95% Cl 2.5–19.0).Keywords
This publication has 34 references indexed in Scilit:
- APOE-??4 in Patients with Alzheimer Disease and Vascular DementiaAlzheimer Disease & Associated Disorders, 1996
- Relation of Coronary Atherosclerosis and Apolipoprotein E Genotypes in Alzheimer PatientsStroke, 1995
- Apolipoprotein E genotypes in Parkinson's disease with and without dementiaAnnals of Neurology, 1995
- The apolipoprotein E alleles as major susceptibility factors for Creutzfeldt-Jakob diseaseThe Lancet, 1994
- Apolipoprotein E4 allele frequency, ischemic cerebrovascular disease, and Alzheimer's disease.Stroke, 1993
- Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset FamiliesScience, 1993
- Prevalence of apolipoprotein E phenotypes in ischemic cerebrovascular disease. A case-control study.Stroke, 1993
- The cognitive efficiency profile: Description and validation in patients with Alzheimer's diseaseInternational Journal of Geriatric Psychiatry, 1991
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984
- Development and validation of a geriatric depression screening scale: A preliminary reportJournal of Psychiatric Research, 1982